The recurring findings were that the substances are not well characterised, that human evidence of effectiveness is thin or absent for the proposed routes of administration, and that immunogenicity risk has not been assessed
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A: Forecasting the future of cardiovascular disease in the United States a policy statement from the American heart association
Some ingredients target pigmentation directly
Chapter 10 - metabolic responses of plants upon different plantpathogen interactions
However, whether these complementary effects translate into additive clinical benefit in patients with established HF remains to be confirmed in dedicated trials
GLP-1 receptor agonists: the science behind the sensation GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the small intestine that signals fullness to the brain